The I-SPY Trials
Non-Profit & Charitable Organizations · 11-50 Employees
View Company Info for Free
Overview
Website
www.ispytrials.orgRevenue
$17.6 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About The I-SPY Trials
Quantum Leap Healthcare Collaborative is dedicated to advancing personalized medicine and innovative treatment options for cancer patients. They focus on bridging care and research to improve patient-centered outcomes through various clinical trials, including the I-SPY trials. Their intended clients include patients seeking personalized treatment options and investigators looking for collaboration in cancer research. The organization actively partners with pharmaceutical companies and community health organizations to enhance the effectiveness of cancer treatments.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is The I-SPY Trials your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if The I-SPY Trials is spiking on competitors!
Product Launch: Get notified when The I-SPY Trials launches new products
Earning: See what the market has to say on The I-SPY Trials recently announced quarterly report
Click to see if The I-SPY Trials had a recent Job posting/layoffs
Check if The I-SPY Trials has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at The I-SPY Trials
Funding: Get notified immidiatlly once The I-SPY Trials has new funding data
The I-SPY Trials, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined The I-SPY Trials as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
The I-SPY Trials is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
The I-SPY Trials is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about The I-SPY Trials.
The I-SPY Trials Tech Stack
A closer look at the technologies used by The I-SPY Trials
The I-SPY Trials News & Media
Exai Bio and Quantum Leap Healthcare Collaborative Announce Expanded Participation in I-SPY 2 Trial to Advance Exai's Novel RNA-based Liquid Biopsy Platform in Breast Cancer
Based on initial positive data, Exai to study a larger cohort of patients to evaluate oncRNAs as a predictive and prognostic biomarker across multiple therapies PALO ALTO, Calif., March 30, 2023 /PRNewswire/ -- Exai Bio today announced a collaboration agreement with Quantum Leap...Delphi Diagnostics™ Inc and Quantum Leap Healthcare Collaborative™ Announce the Inclusion of Delphi's Proprietary Test, SET2,3™, into the Adaptive Randomization Process for the Ongoing I-SPY 2 TRIAL™
HOUSTON, Oct. 27, 2022 /PRNewswire/ -- Delphi Diagnostics, Inc and Quantum Leap Healthcare Collaborative™ (QLHC) announce the inclusion of Delphi's SET2,3™ test for use in the I-SPY 2 TRIAL for patients with locally advanced breast cancer. The SET2,3™ test helps to determine which...I-SPY COVID Trial Sponsored by Quantum Leap Healthcare Collaborative Suggests Addition of Icatibant is Unlikely to Impact Critically Ill COVID-19 Patients
SAN FRANCISCO, April 15, 2021 /PRNewswire/ -- The I-SPY COVID Trial, sponsored by Quantum Leap Healthcare Collaborative (QLHC), was designed to rapidly screen agents that show promise for reducing the time to recovery (defined as reduction in oxygen demand) by approximately 50% or risk of...Quantum Leap Healthcare Collaborative Concludes Apremilast Not Likely to Reduce Time to Recovery or Mortality in Critically Ill Patients in I-SPY COVID Trial
SAN FRANCISCO, March 12, 2021 /PRNewswire/ -- Quantum Leap Healthcare Collaborative (QLHC), the sponsor of the I-SPY COVID Trial, announced that apremilast (Otezla), made by Amgen, has been dropped for futility. Apremilast was chosen for testing in the I-SPY COVID Trial because it is a...
Read more news
Top Non-Profit & Charitable Organizations Companies
Frequently Asked Questions Regarding The I-SPY Trials
Sign Up For FreeTo access detailed company insights
Quantum Leap Healthcare Collaborative is dedicated to advancing personalized medicine and innovative treatment options for cancer patients. They focus on bridging care and research to improve patient-centered outcomes through various clinical trials, including the I-SPY trials. Their intended clients include patients seeking personalized treatment... Read More
